Global Cancer Dx, Inc.

The Lung Cancer Test is a new proprietary blood test that has been proven through clinical studies to determine the risk of lung cancer in early stages.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Tempe, AZ, US
  • Currency USD
  • Founded 2012
  • Employees 10
  • Website --

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free